Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-15

Clinical Trial Update: Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines [Phase 3]

View source ↗

Summary

A Phase 3 trial of the ChimeriVax-Japanese Encephalitis Vaccine in toddlers in Thailand and the Philippines has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ChimeriVax Japanese Encephalitis Vaccine (ChimeriVax JE vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Japanese Encephalitis, Hepatitis A | Phase 3 | Status: COMPLETED | Results posted: 2014-08-15